Values and Responsibilities

Biomoda is committed to scientific excellence and the highest ethical standards as we proceed with the development of diagnostic tests for the detection of early-stage cancers.

Our intention is to provide the global healthcare system with a simple, non-invasive, inexpensive and highly accurate screening technology for the deadliest cancers.  We sincerely believe that the end result of our efforts will be millions of lives saved and a better quality of life for cancer survivors.

The work that we are doing every day in our laboratory stands up to our own high standards.  We follow the Good Clinical Practice (GCP) guidelines, the international ethical and scientific quality standard for designing, conducting, recording and reporting clinical trials that was developed to assure the safety and well-being of trial participants and the credibility of data.

Good Clinical Practice Guidelines

Good clinical practice (GCP) is an international ethical and scientific quality standard for designing, conducting, recording, and reporting trials that involve the participation of human subjects. Compliance with this standard provides public assurance that the rights, safety, and wellbeing of trial subjects are protected, consistent with principles that originated in the Declaration of Helsinki, and that clinical trial data are credible. GCP guidelines provide a unified standard for the European Union (EU), Japan, and the United States to facilitate the mutual acceptance of clinical data by the respective regulatory authorities in these jurisdictions. The guidelines are based on good clinical practices of the European Union, Japan, the United States, Australia, Canada, the Nordic countries, and the World Health Organization (WHO).

Source: Guidance for Industry, E6 Good Clinical Practice: Consolidated Guidance, ICH, April 1996

Useful Links

Site Map Contact Us